SCWorx Corp. (Nasdaq: WORX) announced today that it confirms previously disclosed plans to distribute COVID-19 Rapid Testing Units. Previously, the company announced receiving a committed purchase order from Rethink My Healthcare, a U.S.-based virtual healthcare network, for two million COVID-19 Rapid Testing Units, with provision for additional weekly orders of 2 million units for 23 weeks, valued at $35M per week.
Under the previously disclosed purchase order, SCWorx will supply Rethink My Healthcare with IgM/IgG Rapid Detection Kits. SCWorx continues to anticipate receiving the first 2 million rapid detection kits within approximately two weeks and looks forward to providing incremental updates as they become available.
Building Sustainable Healthcare for an Aging Population
Froedtert ThedaCare Announces Opening of ThedaCare Medical Center-Oshkosh
Touchmark Acquires The Hacienda at Georgetown Senior Living Facility
Contaminants Under Foot: A Closer Look at Patient Room Floors
Power Outages Largely Driven by Extreme Weather Events